Document:

EX-10.6

 Exhibit 10.6 

ARGOS THERAPEUTICS, INC. 

Incentive Stock Option Agreement 

Granted Under 2014 Stock Incentive Plan 
  

	1.	Grant of Option. 

 This agreement evidences the grant by Argos Therapeutics, Inc., a
Delaware corporation (the “Company”), on [            ], 20[__] (the “Grant Date”) to
[            ], an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2014
Stock Incentive Plan (the “Plan”), a total of [            ] shares (the “Shares”) of common stock, $0.001 par value per share, of the Company (“Common
Stock”) at an exercise price of $[            ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on
[            ], 20[__][10 years following the Grant Date] (the “Final Exercise Date”). 

It is intended that the option evidenced by this agreement shall be an incentive stock option as defined in Section 422 of the Internal
Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who
acquires the right to exercise this option validly under its terms. 
  

	2.	Vesting Schedule. 

 This option will become exercisable (“vest”) as to
[25]% of the original number of Shares on the [first] anniversary of the Grant Date and as to an additional [2.0833]% of the original number of Shares at the end of each successive [one-month] period following the first anniversary of
the Grant Date until the [fourth] anniversary of the Grant Date. 
 The right of exercise shall be cumulative so that to the extent the
option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of
this option under Section 3 hereof or the Plan. 
  

	3.	Exercise of Option. 

 (a)    Form of Exercise. Each election
to exercise this option shall be in writing in the Form of Notice of Stock Option Exercise attached hereto as Exhibit A, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, or by such other
method as shall be approved by the Company, in any case together with payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option
may be for any fractional share. 
 (b)    Continuous Relationship with the Company Required. Except as otherwise
provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee or officer of, or consultant or advisor to, the
Company or any parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 

 (c)    Termination of Relationship with the Company. If the
Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final
Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the
Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option
shall terminate immediately upon such violation. 
 (d)    Exercise Period Upon Death or Disability. If the
Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as
specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee),
provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after
the Final Exercise Date. 
 (e)    Termination for Cause. If, prior to the Final Exercise Date, the
Participant’s employment is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment. If, prior to the Final Exercise Date,
the Participant is given notice by the Company of the termination of his or her employment by the Company for Cause, and the effective date of such employment termination is subsequent to the date of delivery of such notice, the right to exercise
this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise agreed that the Participant’s employment shall not be terminated for Cause as provided in such
notice or (ii) the effective date of such termination of employment (in which case the right to exercise this option shall, pursuant to the preceding sentence, terminate upon the effective date of such termination of employment). If the
Participant is party to an employment or severance agreement with the Company that contains a definition of “cause” for termination of employment, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise,
“Cause” shall mean willful misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any
employment, consulting, advisory, nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment shall be
considered to have been terminated for Cause if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

  
 - 2 - 

	4.	Tax Matters. 

 (a)    Withholding. No Shares will be issued pursuant
to the exercise of this option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this
option. 
 (b)    Disqualifying Disposition. If the Participant disposes of Shares acquired upon exercise of this
option within two years from the Grant Date or one year after such Shares were acquired pursuant to exercise of this option, the Participant shall notify the Company in writing of such disposition. 

 

	5.	Transfer Restrictions. 

 This option may not be sold, assigned, transferred, pledged or
otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be exercisable only by the Participant. 

 

	6.	Provisions of the Plan. 

 This option is subject to the provisions of the Plan
(including the provisions relating to amendments to the Plan), a copy of which is furnished to the Participant with this option. 
 IN
WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by its duly authorized officer. This option shall take effect as a sealed instrument. 

 

			
	ARGOS THERAPEUTICS, INC.
		
	By: 	 	 
		
		 	    Name:    ________________________________
		 	    Title:    ________________________________

  
 - 3 - 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2014 Stock Incentive Plan. 
  

	
	PARTICIPANT:
	
	 _____________________________

	
	Address:    ___________________
	
	
                   ___________________

  
 - 4 - 

 Exhibit A 

FORM OF NOTICE OF STOCK OPTION EXERCISE 

                        
    Date: ____________ 
 Argos Therapeutics, Inc. 

4223 Technology Drive 
 Durham, NC 27704 

Attention: Treasurer 
 Dear Sir or Madam: 

I am the holder of an Incentive Stock Option granted to me under the Argos Therapeutics, Inc. (the “Company”) 2014 Stock
Incentive Plan on ______________ for the purchase of _____________ shares of common stock, par value $0.001 per share, of the Company (“Common Stock”) at a purchase price of $_________ per share. 

I hereby exercise my option with respect to _____________ shares of Common Stock, for which I have enclosed ___________________________ in the
amount of _____________. 
 Please register my stock certificate as follows: 

 

									
	 Name(s):
	 	 __________________________________
	 		 		 	
					
		 	 __________________________________
	 		 		 	
					
	 Address:
	 	 __________________________________
	 		 		 	
					
	 Tax I.D. #: 
	 	 __________________________________
	 		 		 	

  
  

	
	Very truly yours,
	
	 _________________________________________

	 Name:____________________________________

  
 - 5 -EX-10.7

 Exhibit 10.7 

ARGOS THERAPEUTICS, INC. 

Nonstatutory Stock Option Agreement 

Granted Under 2014 Stock Incentive Plan 
  

	1.	Grant of Option. 

 This agreement evidences the grant by Argos Therapeutics, Inc., a
Delaware corporation (the “Company”), on [                ], 20[__] (the “Grant Date”) to
[                ], [an][a] [employee], [consultant], [director] of the Company (the “Participant”), of an option to purchase, in whole or in part, on
the terms provided herein and in the Company’s 2014 Stock Incentive Plan (the “Plan”), a total of [                ] shares (the
“Shares”) of common stock, $0.001 par value per share, of the Company (“Common Stock”) at an exercise price of $[                ] per Share.
Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [                ], 20[__] (the “Final Exercise Date”). 

It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the
Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any
person who acquires the right to exercise this option validly under its terms. 
  

	2.	Vesting Schedule. 

 This option will become exercisable (“vest”) as to
[25]% of the original number of Shares on the [first] anniversary of the Grant Date and as to an additional [2.0833]% of the original number of Shares at the end of each successive [one-month] period following the first anniversary of
the Grant Date until the [fourth] anniversary of the Grant Date. 
 The right of exercise shall be cumulative so that to the extent the
option is not exercised in any period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Final Exercise Date or the termination of
this option under Section 3 hereof or the Plan. 
  

	3.	Exercise of Option. 

 (a)    Form of Exercise. Each election
to exercise this option shall be in writing in the Form of Notice of Stock Option Exercise attached hereto as Exhibit A, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, or by such other
method as shall be approved by the Company, in any case together with payment in full in the manner provided in the Plan. The Participant may purchase less than the number of shares covered hereby, provided that no partial exercise of this option
may be for any fractional share. 
 (b)    Continuous Relationship with the Company Required. Except as otherwise
provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant or advisor
to, the Company or any other entity the employees, officers, directors, consultants, or advisors of which are eligible to receive option grants under the Plan (an “Eligible Participant”). 

 (c)    Termination of Relationship with the Company. If the
Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this option shall terminate three months after such cessation (but in no event after the Final
Exercise Date), provided that this option shall be exercisable only to the extent that the Participant was entitled to exercise this option on the date of such cessation. Notwithstanding the foregoing, if the Participant, prior to the
Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option
shall terminate immediately upon such violation. 
 (d)    Exercise Period Upon Death or Disability. If the
Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as
specified in paragraph (e) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee),
provided that this option shall be exercisable only to the extent that this option was exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after
the Final Exercise Date. 
 (e)    Termination for Cause. If, prior to the Final Exercise Date, the
Participant’s employment or other relationship with the Company is terminated by the Company for Cause (as defined below), the right to exercise this option shall terminate immediately upon the effective date of such termination of employment
or other relationship. If, prior to the Final Exercise Date, the Participant is given notice by the Company of the termination of his or her employment or other relationship by the Company for Cause, and the effective date of such employment or
other termination is subsequent to the date of the delivery of such notice, the right to exercise this option shall be suspended from the time of the delivery of such notice until the earlier of (i) such time as it is determined or otherwise
agreed that the Participant’s employment or other relationship shall not be terminated for Cause as provided in such notice or (ii) the effective date of such termination of employment or other relationship (in which case the right to
exercise this option shall, pursuant to the preceding sentence, terminate immediately upon the effective date of such termination of employment or other relationship). If the Participant is party to an employment, consulting or severance agreement
with the Company that contains a definition of “cause” for termination of employment or other relationship, “Cause” shall have the meaning ascribed to such term in such agreement. Otherwise, “Cause” shall mean willful
misconduct by the Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory,
nondisclosure, non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant’s employment or other relationship shall be considered to
have been terminated for “Cause” if the Company determines, within 30 days after the Participant’s resignation, that termination for Cause was warranted. 

  
 -2- 

	4.	Withholding. 

 No Shares will be issued pursuant to the exercise of this option unless
and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this option. 

 

	5.	Transfer Restrictions. 

 (a)    This option may not be sold,
assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this option shall be
exercisable only by the Participant. 
  

	6.	Provisions of the Plan. 

 This option is subject to the provisions of the Plan
(including the provisions relating to amendments to the Plan), a copy of which is furnished to the Participant with this option. 

  
 -3- 

 IN WITNESS WHEREOF, the Company has caused this option to be executed under its corporate seal by
its duly authorized officer. This option shall take effect as a sealed instrument. 
  

			
	ARGOS THERAPEUTICS, INC.
		
	By: 	 	 
		
		 	    Name:    ________________________________
		 	    Title:    ________________________________

  
 -4- 

 PARTICIPANT’S ACCEPTANCE 

The undersigned hereby accepts the foregoing option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges
receipt of a copy of the Company’s 2014 Stock Incentive Plan. 
  

	
	PARTICIPANT:
	
	 _____________________________

	
	Address:    ___________________
	
	
                   ___________________

  
 -5- 

 Exhibit A 

FORM OF NOTICE OF STOCK OPTION EXERCISE 

                        
    Date: ____________ 
 Argos Therapeutics, Inc. 

4223 Technology Drive 
 Durham, NC 27704 

Attention: Treasurer 
 Dear Sir or Madam: 

I am the holder of a Nonstatutory Stock Option granted to me under the Argos Therapeutics, Inc. (the “Company”) 2014 Stock
Incentive Plan (the “Plan”) on ______________ for the purchase of _____________ shares of common stock, par value $0.001 per share, of the Company (“Common Stock”) at a purchase price of $_________ per share. 

I hereby exercise my option with respect to _____________ shares of Common Stock for which I have enclosed ___________________________ in the
amount of _____________. 
 Please register my stock certificate as follows: 

 

									
	 Name(s):
	 	 __________________________________
	 		 		 	
					
		 	 __________________________________
	 		 		 	
					
	 Address:
	 	 __________________________________
	 		 		 	
					
	 Tax I.D. #: 
	 	 __________________________________
	 		 		 	

  
  

	
	Very truly yours,
	
	 _________________________________________

	 Name:____________________________________

  
 -6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}]]